Literature DB >> 18482966

HIV-1 incidence among women of reproductive age in Malawi.

N I Kumwenda1, J Kumwenda, G Kafulafula, B Makanani, F Taulo, C Nkhoma, Q Li, Taha E Taha.   

Abstract

The aim of this study was to determine HIV-1 incidence among women of reproductive age in Malawi. A prospective study design was followed. HIV-1 uninfected women were followed up for nine visits during a period of 12 months. At baseline, women received HIV-1 counselling and testing. At each visit, venous blood was collected for HIV-1 testing. Incidence rate for HIV-1 was estimated using person-years of follow up (PYFU). Risk factors for HIV acquisition were assessed using Cox proportional hazard models. A total of 842 HIV-1 negative women were enrolled in the study. Of these, 787 had subsequent HIV testing and 31 were found HIV-1 infected; an overall incidence rate of 4.51 (95% confidence interval: 2.96-6.06) per 100 PYFU was obtained. Young age, using hormonal injectable contraceptives and bacterial vaginosis were the main predictors of HIV acquisition. The incidence of HIV continues to be high among women in Malawi, and young women appear to be at higher risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482966     DOI: 10.1258/ijsa.2007.007165

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  16 in total

1.  Influence of contraceptive choice on vaginal bacterial and fungal microflora.

Authors:  G Donders; G Bellen; D Janssens; B Van Bulck; P Hinoul; J Verguts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-09       Impact factor: 3.267

2.  Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.

Authors:  Quarraisha Abdool Karim; Ayesha B M Kharsany; Janet A Frohlich; Lise Werner; May Mashego; Mukelisiwe Mlotshwa; Bernadette T Madlala; Fanelesibonge Ntombela; Salim S Abdool Karim
Journal:  Int J Epidemiol       Date:  2010-11-03       Impact factor: 7.196

3.  Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.

Authors:  Brandon L Guthrie; Andrea Introini; Alison C Roxby; Robert Y Choi; Rose Bosire; Barbara Lohman-Payne; Taha Hirbod; Carey Farquhar; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

4.  Medroxyprogesterone acetate impairs human dendritic cell activation and function.

Authors:  N E Quispe Calla; M G Ghonime; T L Cherpes; R D Vicetti Miguel
Journal:  Hum Reprod       Date:  2015-03-03       Impact factor: 6.918

5.  Barriers of Mucosal Entry of HIV/SIV.

Authors:  Ann M Carias; Thomas J Hope
Journal:  Curr Immunol Rev       Date:  2019

6.  Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.

Authors:  Richard P H Huijbregts; Katherine G Michel; Zdenek Hel
Journal:  Contraception       Date:  2014-02-26       Impact factor: 3.375

7.  Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.

Authors:  Allen Matubu; Sharon L Hillier; Leslie A Meyn; Kevin A Stoner; Felix Mhlanga; Mike Mbizvo; Aaron Maramba; Zvavahera M Chirenje; Sharon L Achilles
Journal:  Am J Reprod Immunol       Date:  2019-12-06       Impact factor: 3.886

8.  An inquiry into the uneven distribution of women's HIV infection in rural Malawi.

Authors:  Michelle Poulin; Adamson S Muula
Journal:  Demogr Res       Date:  2011-12-21

9.  Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions.

Authors:  Mbah P Okwen; Bedes Y Ngem; Fozao A Alomba; Mireille V Capo; Savanna R Reid; Ebong C Ewang
Journal:  Harm Reduct J       Date:  2011-02-07

10.  Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

Authors:  Richard P H Huijbregts; E Scott Helton; Katherine G Michel; Steffanie Sabbaj; Holly E Richter; Paul A Goepfert; Zdenek Hel
Journal:  Endocrinology       Date:  2013-01-25       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.